Abstract:
Interstitial cystitis (IC) is a chronic bladder disease for which the exact etiology is unknown and for which there is no reliably effective treatment. However, it is known that the bladder epithelium is often abnormal in IC. We discovered that normal, adult, human bladder epithelial cells are inhibited from proliferating by an anti-proliferative factor (APF) present in IC urine specimens. Inhibited proliferation may cause epithelial abnormalities characteristic of IC such as ulcerations and multiple tears in the bladder epithelium. We further discovered that levels of heparin binding - epidermal growth factor-like growth factor (HB-EGF), a factor known to be important for epithelial cell proliferation and wound healing in other tissues, are abnormally low in the urine of patients suffering from IC as compared to asymptomatic controls or patients with acute bacterial cystitis. The invention herein is directed to the use of urine levels of HB-EGF as a diagnostic marker for IC.
Abstract:
In a computed tomography imaging system, wherein a longitudinally-unbounded object is oriented with respect to a source of cone beam radiation and a detector array, a method is provided for reconstructing an image of the longitudinally-unbounded object. Initially, relative movement between a longitudinally-unbounded object and the cone beam source is established along at least one circular scan path and at least one linear component. The cone beam is operated to irradiate measurable regions of the object while a prescribed orbit is traversed, to project an image of the longitudinally-unbounded object as cone beam data, onto the detector array. A scan field of view is defined, relative to the cone beam geometry. An error propagation distance in a Z direction is determined for the scan. The definition of the scan field of view is then modified, according to error propagation distance, and a set of image reconstruction data is generated, within the modified field of view, from the circular and linear scan paths.
Abstract:
The invention concerns a device for cleaning pipette needles or stirrers, the device comprising a trough (1) which holds cleaning fluid and whose lower region has a fluid duct (3) for filling and/or emptying purposes and whose upper region has at least one feed pipe (6) which leads into at least one nozzle (23) directed into the trough interior. Advantageously, the device has a cylindrical trough (1) and an insert (20) with nozzles (23) which is screwed into the trough (1). The invention further concerns a method of cleaning pipette needles or stirrers, the material to be washed being introduced into the trough interior and sprayed with a washing fluid. The device can also be used to flush the interior of a pipette needle.
Abstract:
A method for determining the sensitivity of at least one nonparaffinophilic microorganism from a specimen obtained from a patient to different antimicrobial agents, and predetermined quantities thereof. The method includes providing at least one receptacle containing an aqueous solution and adjusting the solution to mimic the in vivo clinical conditions of said patient. The method further includes inoculating the solution with the specimen and placing into the receptacle (i) a slide coated with a carbon source and (ii) a predetermined quantity of an antimicrobial agent to be tested. By observing the nonparaffinophilic microorganism growth or lack thereof on the slide, it can be determined whether the predetermined quantity of the antimicrobial agent is effective in inhibiting growth of the nonparaffinophilic microorganism on the slide. An associated apparatus is also disclosed.
Abstract:
A method for detecting or quantitating multiple copies of a repeat sequence in a nucleic acid molecule involving treating the nucleic acid molecule with a probe which is a nucleic acid analogue which is capable of hybridizing to the repeat sequence in the nucleic acid molecule and which is labelled with a detectable substance. The nucleic acid molecule is treated with the probe under conditions permitting the probe to hybridize to the repeat sequences in the nucleic acid molecule. Probe hybridized to complementary repeat sequences is identified in the nucleic acid molecule by directly or indirectly detecting the detectable substance. The method is preferably used for quantitating multiple copies of a repeat sequence in a nucleic acid molecule, preferably a telomere or centromere repeat sequence. Novel probes for use in the method of the invention and kits are described.
Abstract:
The invention pertains to a biosensor with a chemoreceptor for detecting one or more trace components produced by burning. The chemoreceptor is preferably connected to a semiconductor component via an electrolyte. The biosensor can be designed in such a way that only a small number of insect antenna segments, in particular a single such segment, is connected at one end of the chemoreceptor directly or via the electrolyte to the semiconductor component.
Abstract:
An isolated nucleic acid molecule comprising: (i) a primer portion consisting of a contiguous sequence of from 10 to 50 nucleotides capable of hybridising to (a) the target nucleic acid molecule represented by SEQ. ID No. 1, or (b) to the complementary stand thereof; and optionally (ii) a further portion comprising from 1 to 25 nucleotides joined to and immediately 5' to the 5' end of the primer portion.
Abstract translation:一种分离的核酸分子,其包含:(i)引物部分,其由能够与(a)SEQ ID NO:1所代表的靶核酸分子杂交的10至50个核苷酸的连续序列组成。 ID号1,或(b)其互补立场; 和任选地(ii)包含1至25个核苷酸的另外部分,其连接到引物部分的5'末端并立即连接到5'末端。
Abstract:
Improved polyacrylamide-type gels utilizing diacrylyl tertiary amide crosslinkers are disclosed having relatively high monomer: crosslinker ratios in comparison to conventional polyacrylamide gels. The resulting gels have pore structures chemically and physically different from conventional polyacrylamide gels and, when prepared in the optimal monomer: crosslinker ratio, provide superior resolution and structural characteristics over the conventional polyacrylamide gels.
Abstract:
The present invention relates to diagnostic and prognostic assays which assess the phenotype and aggressiveness of a disorder by detecting the stability of a cyclin kinase inhibitor (CKI) protein.
Abstract:
The invention pertains to a novel transcriptional activity factor, Tat-Stimulatory Factor, as well as genes encoding this factor and fragments and biologically functional variants thereof. The Tat-Stimulatory Factor is involved in the regulation of transcriptional elongation of HIV-1 by Tat. The invention also pertains to therapeutics involving the foregoing proteins and genes, and agents that bind to the foregoing proteins and genes. The invention also relates to methods of screening for a compound which binds to Tat-SF1, Tat-SF1-associated kinase and/or a complex of Tat-SF1 and Tat-SF1-associated kinase, as well as methods of screening for compounds which modulate Tat-SF1-mediated transcriptional activation.